Cargando…
SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy
Introduction: Regulatory agencies supported vaccination of pregnant women with SARS-CoV-2 mRNA vaccines, including patients with IBD. No data exist regarding these vaccines in IBD during pregnancy. Aim: To assess the serologic response to two doses of the mRNA SARS-CoV-2 BNT162b2 vaccine in pregnant...
Autores principales: | Avni Biron, Irit, Maayan, Yair, Mishael, Tali, Hadar, Eran, Neeman, Michal, Plitman Mayo, Romina, Sela, Hen Y., Yagel, Simcha, Goldenberg, Rosalind, Ben Ya’acov, Ami, Grisaru Granovsky, Sorina, Ollech, Jacob E., Edelman-Klapper, Hadar, Rabinowitz, Keren Masha, Pauker, Maor H., Yanai, Henit, Goren, Sophy, Cohen, Dani, Dotan, Iris, Bar-Gil Shitrit, Ariella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699106/ https://www.ncbi.nlm.nih.gov/pubmed/36366342 http://dx.doi.org/10.3390/vaccines10111833 |
Ejemplares similares
-
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
por: Edelman-Klapper, Hadar, et al.
Publicado: (2023) -
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center
por: Avni Biron, Irit, et al.
Publicado: (2023) -
A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes
por: Yanai, Henit, et al.
Publicado: (2023) -
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
por: Edelman-Klapper, Hadar, et al.
Publicado: (2022) -
The Impact of Advanced Maternal Age on Pregnancy Outcomes: A Retrospective Multicenter Study
por: Hochler, Hila, et al.
Publicado: (2023)